Repare Therapeutics

Developer of targeted therapies to address the genetic alterations associated with selected tumors

placeMontreal, Montreal, Canada calendar_todayFounded 2016 groups180 employees language reparerx.com

Registered entities

Innovation

29 patent families (3 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace accelerating. Cited 440 times.

YearFilings
20201
20215
20228
202315
202415
202521
20265

Social engagement

Social engagement: 16.5K social following, 3 posts in the last 12 months — around the industry typical range.

Investor mix

15 investors on record; lead investors include Versant Ventures, Bristol-Myers Squibb, Cowen.

Investor typeCountShare
Venture capital640%
Private equity17%
Accelerator & incubator17%
Bank & private debt213%
Other / undisclosed533%

Recent activity

22 Oct 2025
Event
37th AACR-NCI-EORTC Symposium
8 Aug 2025
Milestone
revenue
15 Jul 2025
Partnership
Debiopharm
Coming soon